In a trial of a blood-based multicancer early-detection test added to usual care, the incidence of stage III or IV cancer after three rounds of screening did not differ significantly from that with usual care alone. Full NHS-Galleri trial results: https://t.co/6gXCDymzRy
Editorial: A Step in the Search for the Elusive Holy Grail of Early Detection of Cancer https://t.co/jDmoMv2ZhM
Excited to have attended #WCLC26 and presented my research on Europe's largest cohort #LCINS cohort - 45% of ~10K participants had an actionable driver mutation - with higher rates in Asian and black adults and nearly 2x survival. More to follow soon! #lungcancer
Do driver mutations affect survival differently across ethnic and socioeconomic groups in never-smoker lung cancer?
Sindhu Naidu shares the answer, and what it means for early detection strategies 🎥
#NSCLC#LungCancer#LCsm#WCLC26@IASLC
Delighted to see this work led by Rebecca Giddings published @LungConsultant
🌟👥 47 studies | 7,518 patients
💊 IO/chemo-IO: encouraging HRQoL trends across multiple domains
🎯 Targeted therapies: improvements in dyspnoea & physical functioning
🫁 Surgery: worsening in pain & role functioning at 24 weeks, with persistent dyspnoea at 52 weeks
📈 distinct dyspnoea trajectories over time across treatments
💡 Survival alone does not tell the full story.#PROs #HRQoL #LungCancer #SharedDecisionMaking
https://t.co/GpIsMdbHmy
Excited to share the peer-reviewed protocol for our study on lung cancer in never-smokers. More high-quality data will improve understanding and inform future prevention and care.
@DrSanjayPopat@LungConsultant@BMJOpen_Resp https://t.co/v2tOUIiZpE #lungcancer#LCINS
Delighted to have completed the Health Care Strategy course with Harvard Business School Online — exploring value creation, competition, integration, and innovation in health systems.
Looking forward to applying these business insights in current and future roles.
Healthy lungs Healthier you.
If you’re 55–74 and smoke or used to, look out for your NHS Lung Cancer Screening letter and attend your appointment.
Early action saves lives.
To find out more visit https://t.co/5Ts1D6a5pK
At #BTOG26@LungConsultant presents the latest data from the State of the Nation 2026 report @nlca_uk@NATCAN_news for #lungcancer patients diagnosed in 2024. Read the highlights of the report in our blog here: https://t.co/4XOUUJT6Wu
How do treatments impact quality of life in #NSCLC?
@ucl Dr Giddings systematic review & meta-analysis at #BTOG26 shows:
🎯 Targeted therapies → early improvements
💊 Chemotherapy → temporary worsening
👩⚕️Surgery → longer-term QoL challenges
🫱🫲 Evidence like this is key for shared decision-making in lung cancer care.
Our Patient and Public Report is now available, alongside the full State of the Nation 2026 report.
A big thank you to our Patient and Public Forum for their invaluable contributions.
🔗https://t.co/tfH9l5BtDs
@LungConsultant@HQIP@Roy_Castle_Lung@SCTSUK@btogorg@LCN_UK
Thank you to Professor Neal Navani (@LungConsultant) for an excellent presentation today on Determinants of Lung Cancer Risk in Never-Smokers!
🎥 Watch: https://t.co/nL4Hk3mLOG
🎧 Listen: https://t.co/DiWSBE1ttO
🔔 Subscribe: https://t.co/CCvs8jTyCE
@ekslim@AstraZeneca@Medtronic
⏰ Reminder: Tomorrow (13 Feb | 8:00 AM GMT)
Join us for an exciting session with Professor Neal Navani (@LungConsultant), Professor of Respiratory Medicine at @uclh.
🎙️ Determinants of Lung Cancer Risk in Never-Smokers
🎓 Earn 1 CME credit
💬 Live Q&A
🔗 Register here: https://t.co/ltAviNpkQa
#LungCancer #ThoracicOncology #CME #MedicalEducation
📣The NLCA State of the Nation Report 2026 has been published today.
📘Read the full report for details of care received by people diagnosed with lung cancer in 2024 in England and Wales:https://t.co/8gMm50DNAN
@LungConsultant@HQIP@BTOG@LCN_UK@Roy_Castle_Lung@SCTSUK
📣 The January NLCA Newsletter is out now!
Kick off 2026 with updates on our QI Intervention, the latest data dashboard, the upcoming State of the Nation report, and more.
👉 Read the newsletter here:
https://t.co/tyxHBJvNnL
@HQIP@LungConsultant@Roy_Castle_Lung@SCTSUK
November is Lung Cancer Awareness Month.
Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer.
It’s probably nothing serious, but early diagnosis and treatment can save livesNovember is Lung Cancer Awareness Month.
Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer.
It’s probably nothing serious, but early diagnosis and treatment can save livesNovember is Lung Cancer Awareness Month.
Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer.
It’s probably nothing serious, but early diagnosis and treatment can save livesNovember is Lung Cancer Awareness Month.
Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer.
It’s probably nothing serious, but early diagnosis and treatment can save livesNovember is Lung Cancer Awareness Month.
Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer.
It’s probably nothing serious, but early diagnosis and treatment can save livesNovember is Lung Cancer Awareness Month.
Contact your GP practice if you are experiencing any of these signs and symptoms of lung cancer.
It’s probably nothing serious, but early diagnosis and treatment can save lives.
.@alexandra_p_24, @LeciaSequist and I wrote a new editorial in JAMA (https://t.co/6pULCORCnC) responding to a powerful #lungcancer screening study by Bandi et al (https://t.co/nJwm2KEinm). In 2024, only 18.7% of adults eligible for #lungcancerscreening in the U.S. were screened.
That means most people who should have had an early, treatable cancer found in time… never got that chance.
Even with uptake this low, screening is estimated to save nearly 15,000 lives over 5 years—these are parents, siblings, neighbors, friends. People who are alive today because a simple CT scan found their cancer early.
If every person who qualified under today’s criteria were screened, we could save at least 62,000 lives over 5 years. And the study shows 30,000 more lives could be saved over 5 years among people with a smoking history who don’t even qualify under current USPSTF criteria.
This is an urgent call to action: we need thoughtful but accelerated expansion of lung cancer screening eligibility — and far stronger outreach, access, and policy support to ensure screening reaches everyone who needs it.
🫁 Lung Cancer Awareness Month 🫁
As we raise awareness this November, we’re also looking ahead to a key milestone in the lung cancer audit calendar.
📢📅On 12 Feb 2026, NLCA will publish the State of the Nation Report, alongside the Patient and Public Report.
@LungConsultant
Prof Neal Navani @LungConsultant explores the epidemiology of non-smoking lung cancer — uncovering trends and insights from global data. #nonsmokinglungcancer
Neal Navani kicks off our Essential Update
👉 Epidemiology of Non-Smoking Lung Cancer
🔺 5th commonest cause of cancer deaths in UK
🔺 ⬆️ Incidence
🔺 May = ⬆️ non-smoking popn, not true increase risk
🔺 Risk factors = sex, ethnicity, pesticides, wood burning, pollution, RhA